Reciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3

Toxicology and Applied Pharmacology

Volumn 232, Issue 3, 2008, Pages 408-417

  Zeliadt, Nicholette A ^a   Mauro, Laura J ^b   Wattenberg, Elizabeth V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Extracellular signal regulated kinase; Mitogen activated protein kinase phosphatase 3; Ras

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; RAF PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STABILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

CELL LINE, TUMOR; DUAL SPECIFICITY PHOSPHATASE 6; GENES, RAS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 53349180575     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.08.007     Document Type: Article

References (47)

1. Balmain A., and Pragnell I.B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303 (1983) 72-74
2. Bos J.L., Fearon E.R., Hamilton S.R., Verlaan-de Vries M., van Boom J.H., van der Eb A.J., and Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
3. Camps M., Chabert C., Muda M., Boschert U., Gillieron C., and Arkinstall S. Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 425 (1998) 271-276
4. Camps M., Nichols A., and Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB. J. 14 (2000) 6-16
5. Castelli M., Camps M., Gillieron C., Leroy D., Arkinstall S., Rommel C., and Nichols A. MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alpha. J. Biol. Chem. 279 (2004) 44731-44739
6. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., Wright A., Vanderbilt C., and Cobb M.H. MAP kinases. Chem. Rev. 101 (2001) 2449-2476
7. Chu Y., Solski P.A., Khosravi-Far R., Der C.J., and Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271 (1996) 6497-6501
8. Croonquist P.A., Linden M.A., Zhao F., and Van Ness B.G. Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells. Blood 102 (2003) 2581-2592
9. Cui Y., Parra I., Zhang M., Hilsenbeck S.G., Tsimelzon A., Furukawa T., Horii A., Zhang Z.Y., Nicholson R.I., and Fuqua S.A. Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Res. 66 (2006) 5950-5959
10. Dhillon A.S., Hagan S., Rath O., and Kolch W. MAP kinase signalling pathways in cancer. Oncogene 26 (2007) 3279-3290
11. Dowd S., Sneddon A.A., and Keyse S.M. Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J. Cell. Sci. 111 (1998) 3389-3399
12. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-22
13. Farooq A., and Zhou M.M. Structure and regulation of MAPK phosphatases. Cell Signal 16 (2004) 769-779
14. Franklin C.C., and Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272 (1997) 16917-16923
15. Furukawa T., Sunamura M., Motoi F., Matsuno S., and Horii A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162 (2003) 1807-1815
16. Gomez A.R., Lopez-Varea A., Molnar C., de la Calle-Mustienes E., Ruiz-Gomez M., Gomez-Skarmeta J.L., and de Celis J.F. Conserved cross-interactions in Drosophila and Xenopus between Ras/MAPK signaling and the dual-specificity phosphatase MKP3. Dev. Dyn. 232 (2005) 695-708
17. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., and Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15 (1996) 3621-3632
18. Guan K.L., and Butch E. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J. Biol. Chem. 270 (1995) 7197-7203
19. Kamakura S., Moriguchi T., and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274 (1999) 26563-26571
20. Karlsson M., Mathers J., Dickinson R.J., Mandl M., and Keyse S.M. Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J. Biol. Chem. 279 (2004) 41882-41891
21. Kawakami Y., Rodriguez-Leon J., Koth C.M., Buscher D., Itoh T., Raya A., Ng J.K., Esteban C.R., Takahashi S., Henrique D., Schwarz M.F., Asahara H., and Izpisua Belmonte J.C. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat. Cell. Biol. 5 (2003) 513-519
22. Lefloch R., Pouyssegur J., and Lenormand P. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol. Cell. Biol. 28 (2008) 511-527
23. Legendre F., Dudhia J., Pujol J.P., and Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J. Biol. Chem. 278 (2003) 2903-2912
24. Li C., Scott D.A., Hatch E., Tian X., and Mansour S.L. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134 (2007) 167-176
25. Liu T., Bohlken A., Kuljaca S., Lee M., Nguyen T., Smith S., Cheung B., Norris M.D., Haber M., Holloway A.J., Bowtell D.D., and Marshall G.M. The retinoid anticancer signal: mechanisms of target gene regulation. Br. J. Cancer 93 (2005) 310-318
26. Marchetti S., Gimond C., Chambard J.C., Touboul T., Roux D., Pouyssegur J., and Pages G. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol. Cell. Biol. 25 (2005) 854-864
27. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
28. McCawley L.J., Li S., Wattenberg E.V., and Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274 (1999) 4347-4353
29. Muda M., Boschert U., Dickinson R., Martinou J.C., Martinou I., Camps M., Schlegel W., and Arkinstall S. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271 (1996) 4319-4326
30. Muda M., Theodosiou A., Gillieron C., Smith A., Chabert C., Camps M., Boschert U., Rodrigues N., Davies K., Ashworth A., and Arkinstall S. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J. Biol. Chem. 273 (1998) 9323-9329
31. Murphy L.O., Smith S., Chen R.H., Fingar D.C., and Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell. Biol. 4 (2002) 556-564
32. Owens D.M., and Keyse S.M. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26 (2007) 3203-3213
33. Pages G., Guerin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., and Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286 (1999) 1374-1377
34. Pelech S. Dimerization in protein kinase signaling. J. Biol. 5 (2006) 12.11-12.17
35. Reffas S., and Schlegel W. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem. J. 352 (2000) 701-708
36. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
37. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., and Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 80 (2002) 239-256
38. Shirasawa S., Furuse M., Yokoyama N., and Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260 (1993) 85-88
39. Sweet-Cordero A., Mukherjee S., Subramanian A., You H., Roix J.J., Ladd-Acosta C., Mesirov J., Golub T.R., and Jacks T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. 37 (2005) 48-55
40. Tsang M., Maegawa S., Kiang A., Habas R., Weinberg E., and Dawid I.B. A role for MKP3 in axial patterning of the zebrafish embryo. Development 131 (2004) 2769-2779
41. Vantaggiato C., Formentini I., Bondanza A., Bonini C., Naldini L., and Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5 (2006) 14.1-14.15
42. Warmka J.K., Winston S.E., Zeliadt N.A., and Wattenberg E.V. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 185 (2002) 8-17
43. Warmka J.K., Mauro L.J., and Wattenberg E.V. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J. Biol. Chem. 279 (2004) 33085-33092
44. Woods D.C., and Johnson A.L. Phosphatase activation by EGF family ligands regulates Erk signaling in undifferentiated hen granulosa cells. Endocrinology 336 (2006) 4931-4940
45. Yao Y., Li W., Wu J., Germann U.A., Su M.S., Kuida K., and Boucher D.M. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12759-12764
46. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci. 17 (1998) 1-7
47. Zeliadt N.A., Warmka J.K., and Wattenberg E.V. Mitogen activated protein kinases selectively regulate palytoxin-stimulated gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 192 (2003) 212-221